R-DIM-P-LF11-322
General Information
DRACP ID DRACP00563
Peptide Name R-DIM-P-LF11-322
Sequence PFWRIRIRRPRRIRIRWFP
Sequence Length 19
UniProt ID Not available
PubChem CID Not available
Origin Human lactoferricin derived
Type Native peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
A-375 | Amelanotic melanoma | Carcinoma | LC50=23.3±1.7 µM | MTS assay | 24h | 1 |
SBcl-2 | Serum B cell lymphoma 2 | Lymphoma | LC50=10.4±0.7 µM | MTS assay | 24h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Normal Human Dermal Fibroblasts (NHDF):LC50>101 µM
Target Not available
Affinity Not available
Mechanism Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserin
Nature Anticancer; Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C127H201N45O20
Absent amino acids ACDEGHKLMNQSTVY
Common amino acids R
Mass 299949
Pl 13.35
Basic residues 8
Acidic residues 0
Hydrophobic residues 8
Net charge 8
Boman Index -8906
Hydrophobicity -100
Aliphatic Index 82.11
Half Life
Mammalian: >20 hour
Yeast: >20 hour
E.coli: ?
Extinction Coefficient cystines 11000
Absorbance 280nm 611.11
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 26239537
Title Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine
Doi 10.1016/j.bbamem.2015.07.018
Year 2015
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available